Some thoughts on vax strategy

[Guest guest]

Here is what I am seeing........

 

As we knew--the administration of the nasal mist vaccine in the States is starting the 'pandemic' down there. I have had many reports of people getting sick and needing to be hospitalised--and this will no doubt get way worse. (As a matter of fact since I started this email a couple hours ago I've had a number of reports of personal accounts). There is no doubt that this agenda is PLANNED and not just haphazard as it may appear.

 

As a matter of fact---this just in:

BTW---isn't the timing convenient as vaccines have JUST been put in place? Amazing--these coincidences...

Provinces gear up as second wave of swine flu hits

http://news.sympatico.ctv.ca/abc/home/contentposting.aspx?isfa=1 & feedname=CTV-TOPSTORIES_V3 & showbyline=True & date=true & newsitemid=CTVNews%2f20091023%2fswineflu_2ndwave_091023

 

********

 

So I think it is not a good idea to pooh pooh the flu and number of flu cases as that will blow up in our face.

 

We should instead concentrate on the vaccine reactions---which of course will not be reported in the media. So far we have more or less lumped all vaccines together--and I think we should start differentiating between brands.

 

For instance in Canada we have Arepanrix (or Pandremix) made by GSK

 

http://www.hc-sc.gc.ca/dhp-mps/prodpharma/legislation/interimorders-arretesurgence/prodinfo-vaccin-eng.php#a51

It comes seperately in 2 different vials

 

Antigen:Split influenza virus, inactivated, containing antigen* equivalent to:A/California/7/2009 (H1N1)v-like strain (X-179A) 3.75µg HA** per 0.5mL dose* isolated from virus propagated in eggs** HA = haemagglutinin

Preservative content is 5µg Thimerosal USP per 0.5mL dose or 2.5 micrograms organic mercury (Hg) per 0.5mL dose

Adjuvant:DL-α-tocopherol 11.86 milligrams/0.5mL doseSqualene 10.69 milligrams/0.5mL dose, Polysorbate 80 4.86 milligrams/0.5mL dose

 

The suspension and emulsion vials, once mixed, form a multidose vaccine in a vial. See section Nature and Contents of Container for the number of doses per vial.

 

**************

 

US

 

In the US the FDA has approved 4 different vaccines---none have the oil based adjuvants, (so far not approved but that could change) but the multi vials have around 25 mcg of mercury. (However there is something about Novartis later in this email that may indicate that it does have it)

 

http://askdrsears.com/thevaccinebook/

Sanofi Pasteur’s pandemic H1N1 vaccine is analogous to their regular flu vaccine Fluzone, a brand that has been in use for several years. CSL’s pandemic H1N1 vaccine is analogous to their regular flu vaccine Afluria, a newer player in the flu vaccine market that was first made last year for the 2008/2009 flu season. Novartis’s pandemic H1N1 vaccine is analogous to their regular flu vaccine Fluvirin, which has been around for a few years (previously made by Chiron). MedImmune’s live nasal spray pandemic H1N1 vaccine is analogous to their regular nasal spray Flumist.

***********************

Australia

 

http://www.iol.co.za/index.php?set_id=1 & click_id=31 & art_id=nw20090722103559384C612794

Australia has pre-ordered 21 million shots of vaccine from CSL Biotherapies - enough to cover its whole population.

 

**********

 

UK

 

http://www.cnn.com/2009/HEALTH/10/21/H1n1.flu.vaccinations/index.html#cnnSTCText

The vast majority of people will be offered GlaxoSmithKline's Pandemrix vaccination, which is effective after one dose but made using chicken eggs, according to the Department of Health. Those allergic to eggs will instead be offered Baxter's Celvapan, which requires two doses three weeks apart.

***********

 

Europe

 

As you will notice there are different vaccines for the military and the common people---this is what the big hullaballoo in Germany is about.

 

But notice too....

UNITED STATES EUROPEAN COMMAND????????? Since when???

http://www.eucom.mil/english/FullStory.asp?art={F855C019-0126-4E71-8B8C-860BD1A31FBC}

 

UNITED STATES EUROPEAN COMMAND

There are two separate types of vaccine, one is earmarked for non-uniformed beneficiaries and the other is for uniformed personnel. Vaccine for non-uniformed beneficiaries is an inactivated, injectable vaccine that ismanufactured by Sanofi-Pasteur, it is approved for ages 6 months and older. These vaccination target groups have equal priority: - Pregnant women- Beneficiaries 6 months-24 years old- Caregivers/families of babies less than 6 months old- People 25-64 years old with medical conditions that put them more at risk- Children 6 months to 9 years old will need to get two doses, separated by 4 weeks, to fully protect them- Vaccine will be given to all TRICARE beneficiaries and DoD employeesVaccine for uniformed beneficiaries is an inactivated, injectable vaccine manufactured by Novartis. Priority is deployed or deploying service members, direct healthcare providers, then all other active duty and 7th

CSC Reservists. Novartis and Sanofi-Pasteur are licensed suppliers of seasonal influenza vaccines, and use the same manufacturing processes and quality testing procedures for H1N1 vaccine.

 

***************

 

 

Here is an interesting tidbit from Platelet Disorder Support Association--(you can get the sources at the website--as well as the package insert for most of the vaccines--some great sources) Although I don't see the date---it would appear that it was written a few weeks ago--nevertheless there is excellent information here.

 

http://www.pdsa.org/h1n1.htm

 

Vaccine critics’ concerns – use of adjuvants

Adjuvants are boosters added to vaccines to make them more potent. When the H1N1 vaccines were developed, it was unclear whether they would require adjuvants to prompt immunity against H1N1. Some clinical trials concerning the use of adjuvants are available (15), others are on-going. (10)

The MF59 adjuvant has been know to affect macrophages and cell death. (11). Adjuvants may also affect autoimmunity. (12)(13)

The CDC states that “It is unlikely H1N1 vaccine will be adjuvanted. Definitive information will be available once clinical trial data are available. [if the vaccine is adjuvanted] formulation will vary by provider. For Novartis, vaccine may be preformulated with adjuvant. For CSL, GSK and Sanofi Pasteur, mixing of vaccine and adjuvant at the site of administration will be necessary. Specific information on storage requirements and procedures for mixing vaccine and adjuvant will be provided by CDC. MedImmune vaccine will not be adjuvanted.†(14)

 

****************

****************

 

Does anyone have a list of countries and types of vaccines they get--and what types of ingredients/adjuvants they have? I made a start here--so if you can add to it we can keep better track of what's going on...

 

I an sensing (know) there is going to be a total onslaught of disinformation from MSM now that the vaccines are in place pretty much everywhere---so we should try to keep track of what results in terms of vacc. reactions are happening from which vaccines.

 

Well batten down the hatches---cause we are going for a ride!

 

Looking for the perfect gift? Give the gift of Flickr!